Hi SP3, While reading their sad little ramps ( 3 of them on this thread alone ) and verbal ooze can give one the sh*ts I think they are an essential part of the market environment.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
